Realme C100 5G, Realme C100i Price, Colour Options, Key Features Leak Ahead of Expected April Launch

Realme C100 5G and Realme C100i are expected to launch in Thailand in the first week of April, and they will be the latest entrants in the company’s C series of smartphones. Both handsets are tipped to feature 6.8-inch LCD screens, large 7,000mAh batteries, and IP64-rated builds for dust and splash resistance. They are also expected to run Android 16-based Realme UI. The two models may differ in areas like refresh rate, charging speeds, and design, while still focusing on long battery life and smooth everyday performance.

Realme C100 5G, Realme C100i Launch, Price (Expected)
The Realme C100 5G and Realme C100i are set to launch in Thailand on April 3, according to a report by iPhone-Droid.net. While pricing details are still under wraps, the Realme C100i is expected to be the more affordable option in the lineup.

Ahead of the launch, the upcoming Realme C100 5G has been listed on Thai retailer BaNANA, with the 4GB + 128GB model priced at THB 7,000 (roughly Rs. 20,100) and the 6GB + 128GB variant at THB 7,500 (roughly Rs. 21,500).
Realme C100 5G, Realme C100i Design and Colour Options (Expected)
The Realme C100 5G is expected to feature a squared design with a matte frame and a slim 8.45mm profile. It is shown in a Blooming Purple colour with a floral pattern on the back as well as a Sprouting Green finish. The camera module has a glossy finish.

Samsung Enables Blood Pressure Monitoring on Some Galaxy Watch Models in the US; Watch 9 Development Tipped

Samsung has rolled out blood pressure monitoring for select Galaxy Watch users in the US via the Samsung Health Monitor app. The update allows users to measure and track blood pressure directly from their wrist on supported models. The company said the feature is meant to help users track trends over time and is not intended for medical diagnosis or treatment. Separately, early signs suggest that the Galaxy Watch 9 is already in development, with a firmware file linked to the device spotted on Samsung’s servers.

 

Samsung Galaxy Watch Models Offer Blood Pressure Monitoring After Years

Samsung has enabled blood pressure monitoring for select Galaxy Watch users in the US through the Samsung Health Monitor app. The feature is available on models including the Galaxy Watch 8, Galaxy Watch 8 Classic, Galaxy Watch 7, Galaxy Watch 6 series, and Galaxy Watch 5 series.Users can measure and track their blood pressure directly from the watch, with readings that include systolic and diastolic values along with heart rate. To keep readings accurate, the watch needs to be calibrated every 28 days using a standard upper-arm blood pressure monitor.

This feature joins other health tools on Galaxy Watch devices, such as ECG tracking, irregular heart rhythm alerts, and sleep apnea detection. Samsung also plans to add passive monitoring later this year to show long-term blood pressure trends.

 

Samsung Galaxy Watch 9 Firmware Leaks

Meanwhile, early leaks suggest that the Galaxy Watch 9 is already in development. A firmware file with the model number SM-L345U has been spotted on Samsung’s servers by tipster Mohammed Khatri. Previous reports have associated this model number with the upcoming smartwatch, pointing to internal testing.

 

Samsung usually updates its smartwatch lineup every year, as it introduced the Galaxy Watch 8 series alongside the Galaxy Z Fold 7 and Galaxy Z Flip 7 in July 2025, and the next generation is expected to follow a similar schedule. If that holds, the Galaxy Watch 9 could arrive with the Galaxy Z Fold 8 and Galaxy Z Flip 8 around July 2026.

NeurIPS Reverses Ban on Sanctioned Entities After China Backlash

NeurIPS, one of the world’s leading artificial intelligence conferences, has reversed a controversial policy that would have banned research papers from entities under U.S. sanctions, following strong backlash from China.

The policy, initially introduced earlier in the week, aimed to expand restrictions beyond the U.S. Treasury’s sanctions list. It triggered immediate criticism, particularly from China Association for Science and Technology, which announced a boycott and halted funding support for members planning to attend the conference.

NeurIPS later stated that the broader restriction had been issued in error due to a miscommunication with its legal team. The organization clarified that submission limits would apply only to entities listed under the U.S. Specially Designated Nationals (SDN) list, not all sanctioned organizations.

The conference issued a public apology, acknowledging the disruption caused within the global research community. The incident underscores growing tensions between the United States and China in the field of artificial intelligence, where academic collaboration is increasingly influenced by geopolitical factors.

NeurIPS remains a key global platform where researchers, companies and experts present peer-reviewed AI research and discuss technological advances each year.